Partilhar
Informação da revista
Original articles
Left atrial volume index: Can it provide additional prognostic information in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention?
Filipa Cordeiro, Pedro Silva Mateus, Sílvia Leão, Miguel Moz, Joana Trigo, Catarina Ferreira, Sofia Silva Carvalho, Alberto Ferreira, José Ilídio Moreira
Rev Port Cardiol. 2018;37:799-807
Open access
Original Articles
Editorial comment
Is there still a place for new echocardiographic parameters in risk stratification after acute myocardial infarction?
Ana Teresa Timóteo
Rev Port Cardiol. 2018;37:809-10
Open access
Hemodynamic and clinical performance of Solo stentless bioprosthetic aortic valves
Marta Andrade, Francisca Saraiva, Mário J. Amorim, Benjamim Marinho, Rui J. Cerqueira, André P. Lourenço, Paulo Pinho, Jorge Almeida, Adelino F. Leite-Moreira
Rev Port Cardiol. 2018;37:811-8
Open access
Original Articles
Editorial comment
The place of a stentless aortic bioprosthetic valve
Pedro M. Correia
Rev Port Cardiol. 2018;37:819-20
Open access
Left atrial deformation analysis by speckle tracking echocardiography to predict exercise capacity after myocardial infarction
Ricardo Fontes-Carvalho, Francisco Sampaio, Madalena Teixeira, Catarina Ruivo, José Ribeiro, Ana Azevedo, Adelino Leite-Moreira, Vasco Gama Ribeiro
Rev Port Cardiol. 2018;37:821-30
Open access
Original Articles
Editorial comment
Left atrial function and left ventricular diastolic dysfunction – Just the marionette and its master?
Regina Ribeiras
Rev Port Cardiol. 2018;37:831-4
Open access
Are defibrillators less useful in patients with non-ischemic heart disease?
Rita Marinheiro, Leonor Parreira, Pedro Amador, Catarina Sá, Tatiana Duarte, Marta Fonseca, José Farinha, Cláudia Lopes, Rui Caria
Rev Port Cardiol. 2018;37:835-41
Open access
Original Articles
Editorial comment
The implantable cardioverter-defibrillator according to underlying etiology: Why compare apples and oranges?
João Primo
Rev Port Cardiol. 2018;37:843-5
Open access
The smoker's paradox in acute coronary syndrome: Is it real?
Madalena Coutinho Cruz, Rita Ilhão Moreira, Ana Abreu, Ana Teresa Timóteo, Ramiro Sá Carvalho, Lurdes Ferreira, Rui Cruz Ferreira
Rev Port Cardiol. 2018;37:847-55
Open access
Original Articles
Editorial comment
The smoker's paradox: Not an argument against quitting smoking after acute coronary syndrome
Miguel Mendes
Rev Port Cardiol. 2018;37:857-8
Open access
Review article
Proton pump inhibitors and the risk of severe adverse events – A cardiovascular bombshell?
Nelson Cunha, António Pedro Machado
Rev Port Cardiol. 2018;37:859-63
Open access
Case report
Percutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases
Eduardo Flores-Umanzor, Victoria Martin-Yuste, Guillem Caldentey, Sara Vazquez, Gustavo Jimenez-Britez, Rodolfo San Antonio, Pedro Cepas-Guillen, Margarida Pujol-Lopez, ... Manel Sabaté
Rev Port Cardiol. 2018;37:865.e1-4
Open access
Image in cardiology
Severely complicated emergency blind pericardiocentesis: Evidence from multimodality imaging
Manuel Barreiro-Perez, Ana Martin-Garcia, Marta Alonso-Fernández de Gatta, Pedro L. Sanchez
Rev Port Cardiol. 2018;37:867-8
Open access
Recommended article of the month
Brief Comment Video to the Recommended Article of the Month
Rev Port Cardiol. 2018;37:869
Open access
Erratum
Errata to “Heart failure in numbers: Estimates for the 21st century in Portugal”
Cândida Fonseca, Daniel Brás, Inês Araújo, Fátima Ceia
Rev Port Cardiol. 2018;37:871-2
Open access
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.